You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in


If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.


Tsatsaris, Vassilis MD; Papatsonis, Dimitri MD; Goffinet, François MD, PhD; Dekker, Gus MD, PhD; Carbonne, Bruno MD

Obstetrics & Gynecology:

Objective: To clarify the relative efficacy of nifedipine and beta-agonists for tocolysis.

Data Sources: The literature was searched in the following databases: MEDLINE 1965–1998, Embase 1988–1998, Current Contents 1997–1998, and the Cochrane Database for 1998. We also sought unpublished trials and abstracts submitted to major international congresses. Search terms were: “tocolysis,” “nifedipine,” “calcium channel blocker,” “ritodrine,” “terbutaline,” and “salbutamol.”

Methods of Study Selection: Randomized controlled trials comparing tocolysis with nifedipine and beta-adrenergic agonists during preterm labor were reviewed. In cases with postrandomization exclusions, authors were contacted to obtain intent-to-treat results and to avoid analytical bias. We identified 11 published and two unpublished randomized trials.

Tabulation, Integration, and Results: Data were extracted by two reviewers and analyzed by a blinded biostatistician with RevMan 3.1 software from the Cochrane Collaboration. We analyzed nine relevant randomized controlled trials that included 679 patients. Meta-analysis showed that nifedipine was more effective than the beta-agonists in delaying delivery at least 48 hours [odds ratio (OR) 1.52, 95% confidence interval (CI) 1.03, 2.24], or over 34 weeks (OR 1.87, 95% CI 1.11, 3.15). The agents did not differ as to the incidence of deliveries after 37 weeks (OR 1.29, 95% CI 0.85, 1.96) or the neonatal mortality rate (OR 1.51, 95% CI 0.63, 3.65). Treatment with nifedipine was interrupted significantly less often because of side effects (OR 0.12, 95% CI 0.05, 0.29) and led to better neonatal outcomes (fewer infants with respiratory distress syndrome: OR 0.57, 95% CI 0.37, 0.89) or transferred to neonatal intensive care units (OR 0.65, 95% CI 0.43, 0.97).

Conclusion: With respect to neonatal outcome, nifedipine appears to be more effective than beta-agonists for tocolysis and should be considered for use as a first-line tocolytic agent.

In Brief

Tocolysis with nifedipine gives better neonatal outcome than beta-agonists.

Author Information

Department of Obstetrics and Gynecology, Hôpital Saint-Antoine, Paris, France; Department of Obstetrics and Gynecology, Free University Hospital, Amsterdam, The Netherlands; Epidemiological Research Unit on Women and Children's Health, INSERM U 149, Paris, France; and North Western Adelaide Health Service, University of Adelaide, Adelaide, South Australia.

Address reprint requests to: Bruno Carbonne, MD Department of Obstetrics and Gynecology, Hopital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris, France. E-mail:

We thank J.A. Garcia-Velasco, J.E. Ferguson, E. Janky, C.A.M. Koks, and M. Kupferminc, who kindly provided additional data from their original study for this meta-analysis.

Received July 17, 2000. Received in revised form November 6, 2000. Accepted December 12, 2000.

© 2001 The American College of Obstetricians and Gynecologists